Product Patents

The products and their related methods appearing in the list below may be covered by one or more of the following USA and/or international patents. Other USA patent matters, international equivalent patent matters, and/or distinct international patent matters may also apply or be pending. The reader is hereby placed on notice of Reprise Biomedical’s rights in the USA and/or international patents associated with the following products and their related methods.

To the extent a product, product name, method, feature, or design does not appear on the following list, such omission does not constitute a waiver of any or all intellectual property rights that Reprise Biomedical has established in any of its products, product names, methods, features, or designs. Other Reprise Biomedical products and methods not listed below may also be protected by one or more patents.

This website is provided to satisfy the virtual patent marking provisions of various jurisdictions, including the virtual patent marking provisions of the America Invents Act.

PRODUCT(S)
Miro3D® Wound Matrix
Miro3D® Fibers Wound Matrix
MiroDerm® Wound Matrix
MiroFlex® Biologic Matrix
PATENT NUMBER(S)
US 8,470,520; US 9,974,814; AU 2006282783; CA 2618731; CN 101272815; CN 102861359; EP 1928519 (extended to BE, CH, DE, ES, FR, GB, IT, NL, PL, SE, TR); EP 2431063 (extended to BE, CH, DE, ES, FR, GB, IT, NL, PL, SE, TR); EP 3274007 (extended to DE, FR, GB); HK 1168565; HK 1250493; IL 189418; IN 263193; JP 6089062; KR 101376013; KR 101420585; MX 320910; MX 350338; MX 369594; PL 1928519; PL2431063; RU 2463081; RU 2635478; SG 170731; SG 11201707924
US 8,470,520; US 9,974,814; AU 2006282783; CA 2618731; CN 101272815; CN 102861359; EP 1928519 (extended to BE, CH, DE, ES, FR, GB, IT, NL, PL, SE, TR); EP 2431063 (extended to BE, CH, DE, ES, FR, GB, IT, NL, PL, SE, TR); EP 3274007 (extended to DE, FR, GB); HK 1168565; HK 1250493; IL 189418; IN 263193; JP 6089062; KR 101376013; KR 101420585; MX 320910; MX 350338; MX 369594; PL 1928519; PL2431063; RU 2463081; RU 2635478; SG 170731; SG 11201707924
US 8,470,520; AU 2006282783; CA 2618731; CN 101272815; CN 102861359; EP 1928519 (extended to BE, CH, DE, ES, FR, GB, IT, NL, PL, SE, TR); EP 2431063 (extended to BE, CH, DE, ES, FR, GB, IT, NL, PL, SE, TR); HK 1168565; IL 189418; IN 263193; JP 6089062; KR 101376013; KR 101420585; MX 320910; MX 350338; MX 369594; PL 1928519; PL2431063; RU 2463081; RU 2635478; SG 170731
US 8,470,520; AU 2006282783; CA 2618731; CN 101272815; CN 102861359; EP 1928519 (extended to BE, CH, DE, ES, FR, GB, IT, NL, PL, SE, TR); EP 2431063 (extended to BE, CH, DE, ES, FR, GB, IT, NL, PL, SE, TR); HK 1168565; IL 189418; IN 263193; JP 6089062; KR 101376013; KR 101420585; MX 320910; MX 350338; MX 369594; PL 1928519; PL2431063; RU 2463081; RU 2635478; SG 170731

Refer to the Instructions for Use of each product for a complete listing of its indications, contraindications, warnings, and precautions. Information on this webpage is not a substitute for a product’s Instructions for Use.

CAUTION: Federal (USA) law restricts these products to sale by or on the order of a physician. Not all products are available in all regions. Please contact customer service to confirm availability in your region.

Reprise Biomedical, the Reprise Biomedical logo, Miro3D, Miro3D Fibers, MiroDerm, and MiroFlex are trademarks or registered trademarks of Reprise Biomedical, Inc., in the USA and/or other countries.

SM-00158 Rev. C 05/23